FR2290912A1 - Formulations pharmaceutiques contenant de la l-dopa ou ses derives - Google Patents

Formulations pharmaceutiques contenant de la l-dopa ou ses derives

Info

Publication number
FR2290912A1
FR2290912A1 FR7534769A FR7534769A FR2290912A1 FR 2290912 A1 FR2290912 A1 FR 2290912A1 FR 7534769 A FR7534769 A FR 7534769A FR 7534769 A FR7534769 A FR 7534769A FR 2290912 A1 FR2290912 A1 FR 2290912A1
Authority
FR
France
Prior art keywords
dopa
derivatives
pharmaceutical formulations
formulations containing
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7534769A
Other languages
English (en)
Other versions
FR2290912B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Publication of FR2290912A1 publication Critical patent/FR2290912A1/fr
Application granted granted Critical
Publication of FR2290912B1 publication Critical patent/FR2290912B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7534769A 1974-11-14 1975-11-14 Formulations pharmaceutiques contenant de la l-dopa ou ses derives Granted FR2290912A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP49131304A JPS5157813A (en) 1974-11-14 1974-11-14 Ll dooba mataha sonojudotaiseizaino seiho

Publications (2)

Publication Number Publication Date
FR2290912A1 true FR2290912A1 (fr) 1976-06-11
FR2290912B1 FR2290912B1 (fr) 1978-07-28

Family

ID=15054818

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7534769A Granted FR2290912A1 (fr) 1974-11-14 1975-11-14 Formulations pharmaceutiques contenant de la l-dopa ou ses derives

Country Status (10)

Country Link
US (1) US3961041A (fr)
JP (1) JPS5157813A (fr)
CA (1) CA1047928A (fr)
DE (1) DE2551280A1 (fr)
ES (1) ES442579A1 (fr)
FR (1) FR2290912A1 (fr)
GB (1) GB1485676A (fr)
IT (1) IT1069069B (fr)
NL (1) NL7513370A (fr)
SE (1) SE7512740L (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0252290A2 (fr) * 1986-06-10 1988-01-13 CHIESI FARMACEUTICI S.p.A. Compositions pharmaceutiques contenant le lévodopa méthyl ester, leur préparation et leurs applications thérapeutiques
EP0455475A2 (fr) * 1990-05-03 1991-11-06 Reckitt And Colman Products Limited Utilisation de triclosan pour traiter les affections du canal digestif

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4147768A (en) * 1976-09-13 1979-04-03 Interx Research Corporation Enteric coated digoxin and therapeutic use thereof
JPS54138128A (en) * 1978-04-19 1979-10-26 Akiyama Jiyouzai Kk Double contrast medium for intestine
US4289751A (en) * 1979-06-29 1981-09-15 Merck & Co., Inc. Effervescent enteric-coated formulation of soluble form of erythromycin and therapeutic use thereof
FR2470599A1 (fr) * 1979-12-07 1981-06-12 Panoz Donald Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
GB2130087A (en) * 1982-09-22 1984-05-31 Dr Joachime Helbig Pharmaceutical oral dosage forms of an active agent capable of forming or releasing bicarbonate ions
US4874614A (en) * 1985-03-25 1989-10-17 Abbott Laboratories Pharmaceutical tableting method
US4863741A (en) * 1985-03-25 1989-09-05 Abbott Laboratories Tablet composition for drug combinations
US4663349A (en) * 1985-12-30 1987-05-05 Merck & Co., Inc. Rectally absorbable form of L-dopa
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
GB2189699A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
US4983400A (en) * 1986-06-16 1991-01-08 Merck & Co., Inc. Controlled release combination of carbidopa/levodopa
GB8724763D0 (en) * 1987-10-22 1987-11-25 Aps Research Ltd Sustained-release formulations
US4942039A (en) * 1989-05-09 1990-07-17 Miles Inc. Effervescent analgesic antacid composition having reduced sodium content
US5607969A (en) * 1992-12-24 1997-03-04 Yissum Research Development Company Of The Hebrew University Of Jerusalem L-DOPA ethyl ester to treat Parkinson's disease
US5354885A (en) * 1992-12-24 1994-10-11 Yissum Research Development Company Of The Hebrew University Of Jerusalem Process for preparing ethyl ester of L-DOPA
SI9700186B (sl) 1997-07-14 2006-10-31 Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. Nova farmacevtska oblika z nadzorovanim sproscanjem zdravilnih ucinkovin
US20040151768A1 (en) * 1997-07-23 2004-08-05 Chiesi Farmaceutici S.P.A. Pharmaceutical compositions containing an effervescent acid-base couple
JP2001515855A (ja) * 1997-09-09 2001-09-25 アルザ・コーポレーション 薬剤コーティング組成物と使用方法
US7060734B1 (en) 1997-09-09 2006-06-13 Alza Corporation Pharmaceutical coating composition and method of use
WO1999045934A1 (fr) * 1998-03-11 1999-09-16 Grelan Pharmaceutical Co., Ltd. Preparations entero-solubles effervescentes
US20030091629A1 (en) * 1998-03-27 2003-05-15 Cima Labs Inc. Sublingual buccal effervescent
US20030118645A1 (en) * 1998-04-29 2003-06-26 Pather S. Indiran Pharmaceutical compositions for rectal and vaginal administration
US6350470B1 (en) 1998-04-29 2002-02-26 Cima Labs Inc. Effervescent drug delivery system for oral administration
US6974590B2 (en) * 1998-03-27 2005-12-13 Cima Labs Inc. Sublingual buccal effervescent
US6576250B1 (en) 1998-03-27 2003-06-10 Cima Labs Inc. Pharmaceutical compositions for rectal and vaginal administration
ATE462417T1 (de) * 1998-08-13 2010-04-15 Cima Labs Inc Microemulsionen als feste dosisformen zur oralen verabreichung
IL143070A (en) 1998-11-10 2004-03-28 Teva Pharma Process for the manufacture of l-dopa ethyl ester
IL143071A0 (en) 1998-11-10 2002-04-21 Teva Pharma Dispersible compositions containing l-dopa ethyl ester
KR100299562B1 (ko) 1998-12-29 2001-11-22 우재영 안정성을극대화시킨5-피롤릴-2-피리딜메틸설피닐벤즈이미다졸유도체함유미세과립
AU2005202472B2 (en) * 1999-04-29 2008-12-18 Cima Labs Inc. Effervescent drug delivery system for oral administration
GB0217056D0 (en) * 2002-07-23 2002-08-28 Ass Octel Use
JP5244318B2 (ja) * 2003-12-31 2013-07-24 シーマ・ラブス、インコーポレイテッド 発泡性経口アヘン薬投薬形態およびアヘン薬の投与方法
KR101184138B1 (ko) * 2003-12-31 2012-09-19 시마 랩스 인크. 일반적인 선형 발포성 경구 펜타닐 투약 제형 및 투여 방법
US7858121B2 (en) 2003-12-31 2010-12-28 Cima Labs, Inc. Effervescent oral fentanyl dosage form and methods of administering fentanyl
JP2016029034A (ja) * 2014-07-18 2016-03-03 ナノメガ メディカル コーポレイションＮａｎｏｍｅｇａ Ｍｅｄｉｃａｌ Ｃｏｒｐｏｒａｔｉｏｎ 医薬組成物
JP2017203031A (ja) * 2017-07-12 2017-11-16 スティッチング グロニンゲン セントル フォー ドラッグ リサーチ ｐＨ制御パルス送達システム、その調製法及び使用法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3131123A (en) * 1959-03-13 1964-04-28 Lab Francais De Therapeutique Enteric tablets and manufacture thereof
FR2116256A1 (en) 1970-12-02 1972-07-13 Sobio Lab Enteric - coated l-dopa - for treatment of parkinsonism with reduced gastrointestinal side-effects
US3891696A (en) * 1973-11-02 1975-06-24 Interx Research Corp Novel, transient pro-drug forms of l-dopa

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NEANT *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0252290A2 (fr) * 1986-06-10 1988-01-13 CHIESI FARMACEUTICI S.p.A. Compositions pharmaceutiques contenant le lévodopa méthyl ester, leur préparation et leurs applications thérapeutiques
EP0252290A3 (en) * 1986-06-10 1990-01-24 Chiesi Farmaceutici S.P.A. Pharmaceutical compositions containing levodopa methyl ester, preparation and therapeutic applications thereof
EP0455475A2 (fr) * 1990-05-03 1991-11-06 Reckitt And Colman Products Limited Utilisation de triclosan pour traiter les affections du canal digestif
EP0455475A3 (en) * 1990-05-03 1992-02-26 Reckitt And Colman Products Limited Use of triclosan in the treatment of diseases of the gastrointestinal tract

Also Published As

Publication number Publication date
GB1485676A (en) 1977-09-14
DE2551280A1 (de) 1976-05-20
ES442579A1 (es) 1978-01-16
NL7513370A (nl) 1976-05-18
JPS5157813A (en) 1976-05-20
US3961041A (en) 1976-06-01
SE7512740L (sv) 1976-05-17
IT1069069B (it) 1985-03-25
FR2290912B1 (fr) 1978-07-28
CA1047928A (fr) 1979-02-06
JPS5436645B2 (fr) 1979-11-10

Similar Documents

Publication Publication Date Title
FR2290912A1 (fr) Formulations pharmaceutiques contenant de la l-dopa ou ses derives
BE873973A (fr) Derives de metronidazole et compositions pharmaceutiques en contenant
NL7413085A (nl) Farmaceutisch en/of cosmetisch preparaat uitwendig gebruik.
BE823689A (fr) Compositions pharmaceutiques
AR201108A1 (es) Preparacion desodorante de ambiente solido estable
BE829837A (fr) Nouveaux derives du benzothiophene, leurs procedes de preparation ainsi que les compositions pharmaceutiques les contenant
IL41784A0 (en) Novel optically active derivatives of 1-phenyl-2-aminoethanol,their preparation and pharmaceutical compositions containing them
NO138566C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,1,3-benzotiadiazol-derivater
NL7413848A (nl) Werkwijze voor de bereiding van farmacologisch werkzame 1,2-benzisoxazoolderivaten en gevormd farmaceutisch preparaat, dat een dezer stoffen
NL7410371A (nl) Farmaceutische of cosmetische preparaten.
BE807312A (fr) Compositions pharmaceutiques orales
BE841121A (fr) Acides n-aryl-anthraniliques, leurs procedes de preparation et compositions pharmaceutiques contenant lesdits acides anthraniliques
BE814546A (fr) Nouvelles cephalosporines et compositions pharmaceutiques en contenant
BE803771A (fr) Derives de l'acide 4-hydroxy-3,5-di-alcoyl-phenyl-propionique, leur preparation et leur application
BE856319A (fr) Compositions pharmaceutiques renfermant des derives organiques de la montmorillonite
BE815499A (fr) Compositions pharmaceutiques contenant des derives de triazolo-isoquinoleine
FR2290193A1 (fr) Derives de n2-naphtalenesulfonyl-l-arginine, leur preparation et compositions pharmaceutiques les contenant
BE762426A (fr) Derives calciques d'ethers carboxyalkyliques de gommes de galactomannane
BE809378A (fr) Compositions pharmaceutiques comprenant des sulfonamides
BE827444A (fr) Nouveaux derives de la thyronamine, procede de preparation et compositions pharmaceutiques
BE795132A (fr) Composition a usage medical veterinaire ou cosmetologique contenant un pyrocarbonate difthylique
NL187354C (nl) Werkwijze voor de bereiding van farmaceutische preparaten met prostaglandinewerking en werkwijze voor de bereiding van daarin bruikbare prostaglandinederivaten.
BE817427A (fr) Compositions pharmaceutiques
FR2335228A1 (fr) Derives de la 5-fluoro-pyrimidine-4-one et medicament contenant ces substances
IT8048966A0 (it) Composizione farmaceutica contenente allopurinolo e procedimento di preparazione

Legal Events

Date Code Title Description
ST Notification of lapse